Medigene AG (FRA:MDG1)
Germany · Delayed Price · Currency is EUR 0.0172
+0.0006 (3.61%)
At close: Jun 30, 2026
Medigene AG Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 7.45 | 6.03 | 31.25 | 10.46 | 8 | 10.51 |
Revenue Growth | -17.51% | -80.69% | 198.64% | 30.75% | -23.87% | 38.74% |
Gross Profit Gross Profit Growth | 5.95 | 4.39 | 29.26 | 9.1 | 6.71 | 10.13 |
Operating Income Operating Income Growth | -15.42 | -16.15 | 11.71 | -8.32 | -27.2 | -20.16 |
Net Income Net Income Growth | -15.93 | -16.18 | -8.33 | -9.98 | -28.88 | -19.96 |
Earnings Per Share EPS Growth | -1.26 | -1.32 | -0.68 | -0.81 | -2.35 | -1.63 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Asia Asia Growth | - | - | 0.97 | 5.77 | 2.92 | 4.47 |
Germany Germany Growth | 5.96 | 6.03 | 25.11 | - | - | - |
United States United States Growth | - | - | 5.17 | 4.69 | 5.08 | 5.35 |
Total Total Growth | 7.45 | 6.03 | 31.25 | 10.46 | 8 | 10.51 |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 14.02 | 16.67 | 33.22 | 22.42 | 30.03 | 54.68 |
Total Debt Total Debt Growth | 2.55 | 2.95 | 3.73 | 4.02 | 5.15 | 6 |
Net Cash (Debt) Net Cash Growth | 11.48 | 13.72 | 29.5 | 18.39 | 24.88 | 48.68 |
Net Cash Growth | -45.51% | -53.47% | 60.38% | -26.07% | -48.89% | -2.44% |
Net Cash Per Share Net Cash Per Share Growth | 0.91 | 1.12 | 2.40 | 1.50 | 2.03 | 3.96 |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -14.17 | -15.12 | 11.98 | -10.75 | -24.79 | -16.42 |
Capital Expenditures CapEx Growth | -0.62 | -0.66 | -0.96 | -0.13 | -0.48 | -1.43 |
Free Cash Flow Free Cash Flow Growth | -14.79 | -15.78 | 11.02 | -10.88 | -25.27 | -17.85 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | 79.94% | 72.77% | 93.65% | 87.00% | 83.85% | 96.36% |
Operating Margin | -207.04% | -267.63% | 37.46% | -79.50% | -339.87% | -191.81% |
Pretax Margin | -209.76% | -274.98% | -30.00% | -98.28% | -354.95% | -189.50% |
Profit Margin | -213.98% | -268.10% | -26.66% | -95.41% | -360.85% | -189.91% |
FCF Margin | -198.68% | -261.57% | 35.27% | -103.98% | -315.80% | -169.83% |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Forward PE | - | 8.88 | 8.88 | - | - | - |
P/FCF Ratio | - | - | 4.57 | - | - | - |
PS Ratio | 0.03 | 6.43 | 1.61 | 6.78 | 10.85 | 9.40 |